Navigation Links
Guardian of genome predicts treatment outcomes for childhood cancer
Date:11/5/2007

Researchers have identified a new role for a cancer-prevention gene in the response to drug treatment for childhood cancer.

In humans, the p53 tumour suppressor gene, also known as the guardian of the genome, is known for its role in the prevention of cancer. Mutations in the gene are associated with a high incidence of cancer due to the uncontrolled division of cells which give rise to tumours.

In childhood cancers such as neuroblastoma, p53 mutations are rare at diagnosis, however they can emerge after chemotherapy.

A recent study published in the international journal Cancer Research this month by researchers from the Childrens Cancer Institute Australia for Medical Research (CCIA), and collaborators in the USA, describes a new role for p53 in childhood cancer.

The group showed that by inactivating p53 in neuroblastoma cells, the most common childhood cancer, the cancer cells became resistant to a number of chemotherapy drugs.

Our results provide definitive evidence of a role for p53 as a gene which dictates drug sensitivity in neuroblastoma, said Dr Xue of CCIAs Molecular Diagnostics Program.

These results highlight the importance of p53 status as an indicator of a patients treatment response in neuroblastoma.

Further research has found that p53 does not have one defined function in cancer susceptibility to treatment, adds Dr Xue. In some cancer cell types it does not act as a drug sensitivity gene. It is therefore important to assess the clinical effect of p53 mutations in different cancers in a tissue context.


'/>"/>

Contact: Pearly Harumal
pharumal@ccia.org.au
61-299-625-663
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Guardians Dental Network Experiences Double-Digit Growth
2. Guardian Introduces New Program to Help Employers Control Health Care Premiums
3. One Species Genome Found Within Another
4. Genome Area Linked to Rheumatoid Arthritis
5. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
6. Scientists Map Elephantiasis Parasites Genome
7. Scientists Map Intestinal Bugs Genome
8. Hopkins researchers release genome data on autism
9. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
10. Cats Genome Map Purrfected
11. Domestic cat genome sequenced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: